Annexon Announces Proposed Public Offering of Common Stock tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
With strong Guillain-Barré data, Annexon preps for ANX-005 BLA bioworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bioworld.com Daily Mail and Mail on Sunday newspapers.
Call scheduled for Tuesday, June 4, 2024 at 8:30 a.m. ETBRISBANE, Calif., June 03, 2024 Annexon, Inc. , a clinical-stage biopharmaceutical company developing a new class of complement-based.
Annexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 Data tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Annexon, Inc. (NASDAQ:ANNX – Get Free Report) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 7,570,000 shares, a growth of 25.3% from the April 30th total of 6,040,000 shares. Based on an average trading volume of 1,890,000 shares, the days-to-cover ratio is […]